Carl Riedel is an experienced writer and Open Source Intelligence (OSINT) specialist, known for insightful articles that illuminate underreported issues. Passionate about free speech, he expertly transforms public data into compelling narratives, influencing public discourse.
In December 2021, the U.S. Food and Drug Administration (FDA) warned against using ivermectin for COVID-19 prevention or treatment, emphasizing its primary approval for...
Elon Musk, the CEO of SpaceX and Tesla, has vocally criticized the diversity, equity, and inclusion (DEI) policies in medical schools, asserting that they...
In a comprehensive study published in the Journal of the American Medical Association, researchers delved into the potential risks associated with the COVID-19 bivalent...
